Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.
Open | $7.50 |
Close | $7.47 |
Volume / Avg. | 519.21K / 103.37K |
Day Range | $7.33 - $7.71 |
52 Wk Range | 3.19 - 11.90 |
Market Cap | $244.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 8.71% |
Days to Cover | 15.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.
Other companies in Acrivon Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Atossa Therapeutics (NASDAQ:ATOS) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Acrivon Therapeutics has a consensus price target of $22.78.
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $7.9 last updated September 20, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Acrivon Therapeutics.
Acrivon Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Acrivon Therapeutics.
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.